Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AtriCure Inc ATRC

Healthcare Medical Devices
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze... see more

Recent & Breaking News (NDAQ:ATRC)

AtriCure to Announce First Quarter 2023 Financial Results

Business Wire April 11, 2023

AtriCure to Participate in the 22nd Annual Needham Virtual Healthcare Conference

Business Wire April 3, 2023

AtriCure Reports Fourth Quarter 2022 and Full Year 2022 Financial Results

Business Wire February 21, 2023

AtriCure to Participate in the Oppenheimer 33rd Annual Healthcare Conference

Business Wire February 17, 2023

AtriCure Announces the First Patient Treated in the LeAAPS(TM) Clinical Trial

Business Wire January 31, 2023

AtriCure to Announce Fourth Quarter and Full Year 2022 Financial Results and Participate in 2023 BTIG Medical Technology Conference

Business Wire January 24, 2023

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2022, Provides Financial Outlook for 2023

Business Wire January 9, 2023

AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Business Wire December 20, 2022

AtriCure Wins 2022 NACD Diversity, Equity, & Inclusion Award

Business Wire December 8, 2022

AtriCure to Present at 34th Annual Piper Sandler Healthcare Conference

Business Wire November 8, 2022

AtriCure Reports Third Quarter 2022 Financial Results

Business Wire November 1, 2022

AtriCure to Participate in Upcoming Investor Conferences

Business Wire October 25, 2022

AtriCure to Announce Third Quarter 2022 Financial Results

Business Wire October 11, 2022

AtriCure Announces Investor Education Webcast with Hybrid AF Therapy Key Opinion Leaders

Business Wire September 6, 2022

AtriCure to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Business Wire August 16, 2022

AtriCure Reports Second Quarter 2022 Financial Results

Business Wire August 2, 2022

AtriCure to Participate at Upcoming Investor Conferences

Business Wire July 20, 2022

AtriCure to Announce Second Quarter 2022 Financial Results

Business Wire July 12, 2022

AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial

Business Wire June 7, 2022

AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer

Business Wire June 1, 2022